Article Details

Lexaria Bioscience (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study

Retrieved on: 2024-07-10 15:25:44

Tags for this article:

Click the tags to see associated articles and topics

Lexaria Bioscience (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study. View article details on hiswai:

Excerpt

Investing · Personal ... CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector.

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up